1.Methodological establishment of red blood cell lysis method for handling Rh typing double group samples
Lu LI ; Bin WANG ; Junjie WEI ; Xiaolin SUN ; Haiyun LIU ; Weixin WU ; Yinze ZHANG
Chinese Journal of Blood Transfusion 2026;39(1):114-117
Objective: To establish an accurate and rapid typing method for Rh typing of samples from patients who have received recent blood transfusions by utilizing the difference in osmotic fragility between fresh and old red blood cells. Methods: A lysing solution suitable for destroying old RBCs was prepared. Sixty-one samples collected in our hospital in 2024 with Rh typing of double groups were treated with the lysing solution to remove the old allogeneic red blood cells while preserving the patient's own fresh red blood cells, followed by repeat Rh typing tests. Results: For 61 samples with Rh typing in double groups, 41 were accurately detected identified through the red blood cell lysis method, yielding an identification rate of 67.21%. No significant difference was observed compared to the detection rate of the commonly used capillary centrifugation modified method (χ
=0.103, P>0.05). Conclusion: The red blood cell lysis method provides a novel and rapid experimental approach for clinical use in processing Rh-typed samples that are of double groups, thereby offering a basis for Rh compatibility blood transfusion.
2.Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2–CD16hi subset linked to hepatitis B virus outcomes
Libo TANG ; Yuhao WANG ; Zihan JIN ; Yurong GU ; Zhaofeng ZENG ; Linnan SONG ; Xuan YI ; Lingtao ZHANG ; Yujing ZHANG ; Weiying HE ; Liping WANG ; Weixin HE ; Jianru SUN ; Xiaoqin LAN ; Xiangyong LI ; Shihong ZHONG ; Yongyin LI
Clinical and Molecular Hepatology 2026;32(2):683-705
Background/Aims:
Natural killer (NK) cell function is generally considered dampened in chronic hepatitis B virus (HBV) infection; however, the NK cell pool exhibits phenotypic and functional heterogeneity, and the antibody--mediated effect of NK cells remains less characterized. This study evaluated the dynamic changes in antibody-mediated NK cell responses and the involvement of distinct NK subsets across disease stages and during antiviral treatment.
Methods:
A T-cell receptor-like antibody specific for the HBV core 18–27 peptide (cTCRL-Ab) was used to determine the antibody-mediated effect of NK cells, and an array of NK cell surface markers were analyzed in cross-sectional and longitudinal cohorts of patients with chronic HBV infection. Single-cell RNA sequencing (scRNA-seq) was performed to identify the heterogeneity of NK subsets.
Results:
The cTCRL-Ab enabled the detection of NK cell cytolytic activity and IFNγ production. Notably, cTCRL-Ab-mediated NK cell responses were compromised in chronically HBV-infected patients, particularly in those receiving pegylated interferon-α (Peg-IFNα), which was associated with the downregulation of CD16 expression. Correspondingly, Peg-IFNα inhibited cTCRL-Ab-mediated NK cell function by reducing CD16 expression in vitro. scRNA-seq revealed that CD16 downregulation occurred mainly within a dysfunctional CD16hi NK subset exhibiting exhaustion properties. In contrast, an activated CD16hiNK subpopulation (CX3CR1⁺KLRC2–CD16hi) with high cytotoxicity was enriched in patients who experienced favorable treatment responses. Furthermore, the intrahepatic CX3CR1+KLRC2–CD16hi subset tended to exhibit functional restoration in HBsAg-loss individuals.
Conclusions
Our data contribute to the understanding of antibody-mediated responses of NK cells in chronic HBV infection, and highlight a previously unappreciated functional CX3CR1+KLRC2–CD16hiNK subset as a potential therapeutic target.
3.Clinical features and influencing factors of misophonia severity
Weixin ZHANG ; Keyu ZHAO ; Yaping WU ; Yuehan ZHAO
Journal of Public Health and Preventive Medicine 2026;37(5):87-91
Objective To investigate clinical features and severity influencing factors of misophonia in psychiatric outpatients. Methods A total of 130 misophonia patients from Weifang People's Hospital (Oct 2023-Jun 2025) were assessed with scales and psychiatric interviews. Linear regression was used to analyze influencing factors. Results Among the 52.3% reported gradually worsening symptoms. Primary triggers were human oronasopharyngeal sounds (65.3%). Core emotional responses were disgust (86.2%) and anger (61.5%), with 75.4% experiencing loss of control. Common coping strategies included covering ears/wearing earplugs (66.1%) and avoidance (64.6%). Mean Amsterdam Misophonia Scale-Revised score was 26.4±5.2, indicating severe social dysfunction. Common comorbidities were obsessive-compulsive disorder (11.5%), depressive disorder (8.5%), and social anxiety disorder (5.4%). Multivariate analysis identified depressive disorder, social anxiety disorder, obsessive-compulsive disorder and post-traumatic stress disorder as independent factors affecting severity (all P<0.05). Conclusion Misophonia follows a chronic course with severe impairment in social functioning and quality of life. Obsessive-compulsive disorder, depressive disorder, social anxiety disorder, and post-traumatic stress disorder are key factors influencing symptom severity.
4.A survey on Chinese physicians’cognition,attitudes,and practices regarding biosimilars and their clinical switching
Liyang GAO ; Lijuan ZUO ; Huiting PENG ; Weixin XU ; Li ZHANG ; Haisheng CHEN ; Jing SHI
China Pharmacy 2026;37(18):2363-2368
OBJECTIVE To investigate the cognition, attitudes, and current practices of Chinese physicians regarding biosimilars and their clinical switching, so as to provide a basis for the rational clinical application of biosimilars in China and the improvement of related policies.METHODS A national cross-sectional online questionnaire survey was conducted in 2025. Quota sampling was adopted, with quotas based on physicians’ sex, city tier, and specialty. Questionnaire invitations were distributed to licensed physicians, and physicians who had prescribed monoclonal antibody biosimilars were included for analysis. The questionnaire covered their familiarity with biosimilars, attitudes, clinical switching practices, and reasons. Data were processed using reliability and validity tests, dispersion analysis, and cross-tabulation analysis.RESULTS The questionnaire scale showed good reliability and validity, with Cronbach’s α coefficient >0.7 and KMO value >0.6. A total of 2 071 survey invitations were distributed, and 300 valid questionnaires were returned, with an effective response rate of 14.5%. Among the respondents, 75.3% had prescribed 3-5 types of monoclonal antibody biosimilars; only 35.3% were aware that China currently has no clear regulatory provisions on biosimilar switching; 46.3% and 47.3% of respondents believed that there was no difference in safety and efficacy, respectively, between biosimilars and originator products; 63.0% of respondents were concerned about the immunogenicity risk of long-term switching between originator drugs and biosimilars. A total of 92.3% of respondents had experience with biosimilar switching, 87.7% of which involved switching from originator products to biosimilars, and 28.2% of respondents had completed three or more switches in the same patient. Among the primary reasons for switching, non-medical factors accounted for 57.4%, higher than medical factors at 42.6%; “lower treatment cost after switching” was the most important reason for switching; 95.3% of respondents believed that informed consent should be obtained from patients before switching.CONCLUSIONS The surveyed physicians had basic knowledge of biosimilars, but their understanding of the relevant regulations of the national drug regulatory authority was insufficient. Although most physicians were concerned about the risks of non-medical switching, clinical switching was mostly driven by non-medical factors. It is recommended to strengthen policy education for medical professionals and standardize clinical switching behavior. The National Medical Products Administration should also promptly improve the interchangeability review standards and post-marketing surveillance system for biosimilars, so as to promote the rational use of biosimilars.
5.Elimination of daratumumab interference with IgG antibody titer detection based on the erythrocyte CD38 antigen masking strategy
Lu LI ; Bin WANG ; Junjie WEI ; Haiyun LIU ; Chuhui YIN ; Weixin WU ; Yinze ZHANG
Chinese Journal of Blood Transfusion 2026;39(9):1269-1272
Objective: To eliminate the interference of daratumumab (DARA) in the titer determination of IgG antiA/antiB antibodies, resolve the discrepancy between test results and theoretical expectations, and obtain accurate and reliable test results. Methods: A group A blood sample with a positive IgG antiA titer result was confirmed to have a recent history of DARA administration. After removal of IgM antibodies from the plasma, IgG antiA/antiB titers were determined using the antiglobulin test card with a serial twofold dilution method, following pretreatment of reagent red blood cells with a rabbit antihuman CD38 functional monoclonal antibody. Results: Without pretreatment with the rabbit antihuman CD38 functional monoclonal antibody, the IgG antiA titer of the sample was 128. After pretreatment, the IgG antiA titer became negative. Conclusion: Based on the red blood cell CD38 antigen masking strategy, pretreatment of red blood cells with a rabbit antihuman CD38 functional monoclonal antibody can eliminate the interference of DARA on the titer determination of IgG antibodies, thereby providing accurate diagnostic evidence and decision support for clinical treatment.
6.Analysis and Prediction of Disease Burden of Depression in Old Age in China from 1990 to 2021
Xiaolin BAO ; Hongjuan WEI ; Xinxin BIAN ; Xiumei MA ; Yin GAO ; Yingyan ZHANG ; Wei LIU ; Yuexian MA ; Weixin ZHANG ; Xuewen YANG
Medical Journal of Peking Union Medical College Hospital 2025;16(2):361-369
Objective To analyze the trends in disease burden and risk factors of depression among the elderly population in China from 1990 to 2021,and to provide a theoretical basis for the prevention,treatment,and policy-making of geriatric depression in China.Methods Data on the disease burden of geriatric depres-sion in China from 1990 to 2021,including the number of incident cases,disability-adjusted life years(DALYs),incidence rate,and DALY rate,were extracted from the 2021 Global Burden of Disease(GBD)database.The Joinpoint regression model was used to analyze the trends by calculating the annual percentage change(APC)and average annual percentage change(AAPC).The autoregressive integrated moving average(ARIMA)model was employed to predict the disease burden of geriatric depression over the next five years.Population attributable fractions(PAFs)were used to describe the risk factors for geriatric depression in China in 1990 and 2021.Results From 1990 to 2021,the number of incident cases and the incidence rate of geri-atric depression in China showed an overall upward trend.The most significant increase in incidence was ob-served in the 60-64 age group,while the prevalence rate increased notably in the ≥ 95 age group.The DALY rate showed the most pronounced upward trend in the 65-69 age group.The incidence,prevalence,and DALY rates of geriatric depression were higher in women than in men.Major risk factors included child-hood sexual abuse and intimate partner violence,with the impact of intimate partner violence being particular-ly significant among women.The ARIMA model predicted that the incidence,prevalence,and DALY rates of geriatric depression in China would decline over the next five years,with a greater decline observed in women than in men.Conclusions From 1990 to 2021,the incidence,prevalence,and DALY rates of geriatric de-pression in China showed an overall upward trend,with higher rates observed in women than in men.Greater attention should be paid to the elderly female population,with a focus on early prevention to reduce the dis-ease burden of geriatric depression.
7.Efficacy of Yanling Yishou Prescription Combined with Aerobic Exercise in Intervention of Heart and Spleen Deficiency Syndrome in Middle-aged White-collar Workers with "Stress-induced Aging": A Randomized and Controlled Trial
Weixin ZHANG ; Changyin LI ; Qing ZHOU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(16):184-191
ObjectiveTo investigate the clinical efficacy and safety of Yanling Yishou prescription combined with aerobic exercise in the intervention of heart and spleen deficiency syndrome in middle-aged white-collar workers with "stress-induced aging". MethodsA randomized, controlled, and open-label trial was conducted involving 156 patients with stress-induced aging and heart and spleen deficiency syndrome who were recruited from the Affiliated Hospital of Nanjing University of Chinese Medicine. Participants were randomly assigned via a central randomization system into an intervention group and a control group, with 78 cases in each group. The intervention group received Yanling Yishou prescription combined with a standard aerobic exercise protocol, while the control group received the standard aerobic exercise protocol only. The composition of Yanling Yishou prescription was derived from Qinggong Medical Records: 10 g Ziziphi Spinosae Semen, 10 g Codonopsis Radix, 10 g Astragali Radix, 10 g Paeoniae Radix Alba, 10 g Angelicae Sinensis Radix, 10 g Rehmanniae Radix, 10 g Atractylodis Macrocephalae Rhizoma, 10 g Poria, and 3 g Glycyrrhizae Radix et Rhizoma, decocted in water and administered 2 hours after breakfast and dinner, respectively. The aerobic exercise protocol was prescriptionted according to the 2017 guidelines of the American College of Sports Medicine, consisting of a 5-minute warm-up, a progressively increasing exercise stage (starting at 5 minutes and increasing by 1-2 minutes daily up to a maximum of 20 minutes), and a 10-minute cool-down. Both groups were treated for 28 days and followed up for 35 days. Outcome measures included Checklist Individual Strength (CIS), sleep quality indicators ( total sleep time, light sleep, and deep sleep), traditional Chinese medicine (TCM) symptom scores for heart and spleen deficiency syndrome, Hospital Anxiety and Depression Scale (HADS), physical function score from the SF-36 scale (SF-36 PF), Pain Visual Analog Scale (Pain VAS), and vital signs. ResultsCompared with baseline, the intervention group showed a significantly greater reduction in CIS scores and improvement in sleep quality (P<0.05, P<0.01), while the control group showed no significant changes. Post-treatment comparisons between groups revealed that the intervention group achieved significantly better outcomes in fatigue reduction and sleep improvement (P<0.05, P<0.01). In terms of TCM syndrome scores, the intervention group showed significant improvements in fatigue, frequent awakening, vivid dreaming, poor appetite, palpitations, and loose stools (P<0.05, P<0.01), while the control group showed no significant improvement in poor appetite, palpitations, or loose stools. After treatment, the intervention group showed significantly better improvements in fatigue, frequent awakening, vivid dreaming, and palpitations compared to the control group (P<0.05, P<0.01). No significant differences were observed between the two groups in SF-36 PF, HADS, and Pain VAS scores before and after treatments. No serious adverse events occurred in either group during the study period. ConclusionYanling Yishou prescription combined with aerobic exercise can alleviate symptoms such as fatigue, frequent awakening, vivid dreaming, and palpitations, improve sleep quality, and alleviate heart and spleen deficiency symptoms, thereby improving the quality of life in middle-aged white-collar workers with stress-induced aging.
8.Morita therapy for misophonia: a case report
Xinyu SUO ; Lijun WANG ; Peipei WANG ; Weixin ZHANG ; Yaozhong ZHANG ; Yuehan ZHAO
Sichuan Mental Health 2025;38(4):381-384
Misophonia is a psychophysiological and behavioral disorder characterized by an individual's low tolerance to specific sounds, leading to intense negative emotional experiences and physiological responses. Currently, there is no standardized and universally effective treatment for misophonia in clinical practice worldwide. This article reports the case of an 18-year-old male patient with misophonia who showed poor response to sertraline combined with exposure and response prevention therapy. Subsequently, the patient received 8 weeks of Morita therapy (once a week, 50 minutes per session), with symptomatic improvement. By presenting this case, we explore the potential efficacy of Morita therapy in treating misophonia, aiming to provide a reference for its clinical management. [Funded by Scientific Research Development Fund Project of Shandong Second Medical University (number, 2024FYM034)]
9.Effects of acupuncture on the hypothalamic-pituitary-ovarian axis and FSH/cAMP signaling pathway in aged rats.
Yaoyao ZHU ; Yaqian YIN ; Huanfang XU ; Li YANG ; Weixin LI ; Chenchen SU ; Rong ZHANG ; Yigong FANG
Chinese Acupuncture & Moxibustion 2025;45(2):200-208
OBJECTIVE:
To explore the mechanism of acupuncture on improving ovarian hypofunction in aged rats from two perspectives: the overall regulation of the hypothalamic-pituitary-ovarian (HPO) axis and the local ovarian follicle stimulating hormone (FSH)/cyclic adenosine monophosphate (cAMP) signaling pathway.
METHODS:
Six 3-month-old female SPF-grade Sprague-Dawley (SD) rats were selected as the blank group. Another twelve 9-month-old female SD rats were randomly divided into a model group and an acupuncture group, with six rats in each. The acupuncture group received acupuncture at "Baihui" (GV20), "Guanyuan" (CV4), and bilateral "Ciliao" (BL32) for 20 min per session, once every other day, for a total of 10 sessions. Vaginal smear tests were performed daily to observe the estrous cycle of the rats. Ovarian morphology was observed using HE staining, and follicles at various stages were counted. ELISA was used to detect levels of serum FSH, luteinizing hormone (LH), estradiol (E2), anti-müllerian hormone (AMH), hypothalamic gonadotropin-releasing hormone (GnRH), pituitary FSH and LH, and ovarian cAMP. Immunohistochemistry and Western blot were used to detect the protein expression of ovarian cAMP protein kinase catalytic subunit, FSH receptor (FSHR), and P450. Real-time quantitative PCR was used to measure mRNA expression levels of FSHR and P450 in ovarian tissue.
RESULTS:
Compared with the blank group, the model group showed an increased rate of estrous cycle disorder (P<0.01), reduced granulosa cell layers with blurred boundaries and disordered arrangement, decreased numbers of developing follicles at all stages, and increased numbers of atretic follicles (P<0.01); the serum levels of FSH and LH were increased (P<0.01), while E2 and AMH levels were decreased (P<0.01); the hypothalamic GnRH and pituitary FSH and LH levels were elevated (P<0.01), and ovarian cAMP level was decreased (P<0.01); the positive expression and protein expression of ovarian P450, cAMP protein kinase catalytic subunit, and FSHR were reduced (P<0.01), and ovarian FSHR and P450 mRNA expression was decreased (P<0.01). Compared with the model group, the acupuncture group showed a reduced rate of estrous cycle disorder (P<0.01), clear granulosa cell margins, increased numbers of primordial and secondary follicles, and decreased numbers of atretic follicles (P<0.01); the serum FSH and LH levels were decreased (P<0.01, P<0.05), while E2 and AMH levels were increased (P<0.05, P<0.01); the hypothalamic GnRH and pituitary FSH and LH levels were decreased (P<0.01, P<0.05), and ovarian cAMP level was increased (P<0.01); the positive expression and protein expression of ovarian P450, cAMP protein kinase catalytic subunit, and FSHR were elevated (P<0.01), and ovarian FSHR and P450 mRNA expression was increased (P<0.01).
CONCLUSION
Acupuncture could delay ovarian hypofunction in aged rats, possibly through regulating the HPO axis and the FSH/cAMP signaling pathway.
Animals
;
Female
;
Rats
;
Rats, Sprague-Dawley
;
Follicle Stimulating Hormone/genetics*
;
Acupuncture Therapy
;
Ovary/metabolism*
;
Signal Transduction
;
Humans
;
Cyclic AMP/metabolism*
;
Hypothalamo-Hypophyseal System/metabolism*
;
Aging/metabolism*
;
Hypothalamus/metabolism*
;
Pituitary Gland/metabolism*
;
Gonadotropin-Releasing Hormone/metabolism*
10.Construction and preliminary application of an information platform for health management in glaucoma patients
Xiaoxin GUO ; Weixin ZHENG ; Chunyan YANG ; Yu ZHANG ; Wenmin HUANG
China Modern Doctor 2025;63(27):62-65,126
Objective To construct a health management information service platform for glaucoma patients to achieve continuous care.Methods The architecture of the health management information service platform for glaucoma patients was designed,and the platform was developed and implemented.Results A WeChat mini program-based health management information service platform was developed,consisting of a medical staff interface,a patient interface,and a backend management center.The platform integrates functions such as whole-process disease tracking,surgical management,medication and follow-up record-keeping with reminders,communication for follow-ups,and health education.From March 2021 to March 2024,the platform registered 2764 patients and 45 medical staff,with a total of 10 947 platform interactions.An overall assessment with the post-study system usability questionnaire yielded a mean score of 28.2,indicating good user experience.Conclusion This platform realizes closed-loop management for continuous care of glaucoma patients and provides a practical reference for the development and exploration of health management information service platforms.


Result Analysis
Print
Save
E-mail